Friday, January 22, 2010

Personalized Medicine


On Jan. 19th and 20th we presented our microarray technology to ~400 attendees interested in the future of personalized medicine applications. After attending this event, it is clear to us that Arrayit technology is ahead of the competition in several key areas. The areas include high throughput genotyping, protein/peptide microarrays, and measuring gene expression.

The most interesting talk was presented by Dr. Elizabeth Mansfield. She is the Director of the Personalized Medicine Staff in the Office of In Vitro Diagnostic Devices in the Center for Devices, FDA, where she is developing a program to address companion and novel diagnostic devices. Hearing details about the regulations that are being implemented to protect the public health gives us a lot of confidence that our technology is best suited to meet the needs of our healthcare system.

It was a great event and we look forward to our work in this area. If you have any questions about how our technology is being implemented in personalized medicine applications, please contact me at todd@arrayit.com